Share on StockTwits

Span-America Medical (NASDAQ:SPAN) VP Robert E. Ackley acquired 1,000 shares of the company’s stock on the open market in a transaction that occurred on Thursday, August 7th. The shares were purchased at an average cost of $18.65 per share, with a total value of $18,650.00. Following the completion of the purchase, the vice president now directly owns 10,993 shares of the company’s stock, valued at approximately $205,019. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Span-America Medical (NASDAQ:SPAN) opened at 19.08 on Friday. Span-America Medical has a 1-year low of $18.09 and a 1-year high of $25.02. The stock’s 50-day moving average is $20.21 and its 200-day moving average is $20.84. The company has a market cap of $56.5 million and a price-to-earnings ratio of 18.12.

Span-America Medical (NASDAQ:SPAN) last posted its quarterly earnings results on Monday, August 4th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by $0.21. The company had revenue of $13.30 billion for the quarter, compared to the consensus estimate of $18.62 billion. Analysts expect that Span-America Medical will post $0.86 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Thursday, September 4th. Shareholders of record on Thursday, August 14th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 3.12%. The ex-dividend date of this dividend is Tuesday, August 12th. This is a positive change from Span-America Medical’s previous quarterly dividend of $0.14.

Separately, analysts at Sidoti downgraded shares of Span-America Medical from a “buy” rating to a “neutral” rating in a research note on Wednesday.

Span-America Medical Systems, Inc manufactures and distributes a variety of therapeutic support surfaces and related products utilizing polyurethane and other foam products for the medical, consumer and industrial markets.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.